Silencing the Adipocytokine NOV: A Novel Approach to Reversing Oxidative Stress-Induced Cardiometabolic Dysfunction

Objective: NOV/CCN3 is an adipocytokine recently linked to obesity, insulin resistance, and cardiometabolic dysfunction. NOV is manufactured and secreted from adipose tissue, with blood levels highly correlated with BMI. NOV levels are increased in obesity and a myriad of inflammatory diseases. Elev...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldman, Maayan, Singh, Shailendra P., Shen, Hsin-Hsueh, Alex, Ragin, Rezzani, Rita, Favero, Gaia, Hochhauser, Edith, Kornowski, Ran, Arad, Michael, Peterson, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564193/
https://www.ncbi.nlm.nih.gov/pubmed/36231029
http://dx.doi.org/10.3390/cells11193060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564193/
https://www.ncbi.nlm.nih.gov/pubmed/36231029
http://dx.doi.org/10.3390/cells11193060

Ejemplares similares